CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Preliminary Final Report, page-2

  1. 227 Posts.
    lightbulb Created with Sketch. 46
    R&D up, corporate down, product launched in US and a medicine that can treat dog skin disease in the pipeline.. Still can’t believe this hasn’t popped yet.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.